The data, said sources, is mainly pertaining to production volumes, capacity, exports, domestic sales and distribution along with prices
The National Pharmaceutical Pricing Authority (NPPA) invoked the para 32 (ii) of the Drug Price Control Order, 2013 to grant the exemption to the indigenously developed stent
The NPPA has said it will allow different prices for drug eluting stents only if the manufacturers can prove the superiority of stents